Press Releases - 2001 to 2005

Press Releases - 2001 to 2005

SPress Relases 2005

Sabinsa Corporation Awarded Thomas Alva Edison Patent Award for Tetrahydropiperine

Sabinsa Corporation Awarded Thomas Alva Edison Patent Award...

Press Release - 2005

Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals,...

21 July 2005
Sabinsa Expands In India

Sabinsa Expands In India

Press Release - 2005

Drawing on its expertise in providing standardized extracts, Sabinsa Corp., is investing $3 million to...

14 March 2005

SPress Relases 2004

Sabinsa Corporation is Awarded Thomas Alva Edison Patent Award

Sabinsa Corporation is Awarded Thomas Alva Edison Patent...

Press Release 2004

Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals,...

23 November 2004
Sabinsa Corporation Granted Patent for Tetrahydrocurcuminoids

Sabinsa Corporation Granted Patent for Tetrahydrocurcuminoids

Press Release 2004

US Patent # 6,653,327 titled "Cross-regulin composition of turmeric-derived tetrahydrocurcuminoids for skin lightening and protection...

27 February 2004

SPress Relases 2003

FDA Issued Interim Final Regulations Implementing Sections 305 And 307 of The Public Health Security And Bioterrorism Preparedness Act Which Are Effective On December 12, 2003

FDA Issued Interim Final Regulations Implementing Sections 305...

Press Release - 2003

This regulation pertains solely to domestic and foreign facilities that manufacture/process, pack, and hold food,...

18 November 2003
Sabinsa Obtains Emergency Injunction Against Alchem International In Patent Infringement Case at SupplySide East

Sabinsa Obtains Emergency Injunction Against Alchem International In...

Press Release - 2003

For the first time, a foreign company engaging in alleged Intellectual Property (IP) theft at...

09 May 2003
Sabinsa Successfully Defends ForsLean® Patent Infringement Lawsuit Against GCI Nutrients

Sabinsa Successfully Defends ForsLean® Patent Infringement Lawsuit Against...

Press Release - 2003

Sabinsa Corporation has once again successfully protected its intellectual property (IP). Mark C. Sysler, Sabinsa’s...

22 April 2003
Indian Dignitaries Inagurate Sabinsa's Supercritical Fluid (CO2) Facility

Indian Dignitaries Inagurate Sabinsa's Supercritical Fluid (CO2) Facility

Press Release - 2003

Bangalore, India - Sami Labs Limited, the research and manufacturing arm of Sabinsa Corporation, recently...

13 January 2003

SPress Relases 2002

Sabinsa Wins ForsLean® Patent Infringement Suit Against Indfrag Ltd.

Sabinsa Wins ForsLean® Patent Infringement Suit Against Indfrag...

Press Release - 2002

Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment...

11 October 2002
Sabinsa Develops L-(+)-Selenomethionine HPLC Assay Procedure, Shares Method With Analytical Labs

Sabinsa Develops L-(+)-Selenomethionine HPLC Assay Procedure, Shares Method...

Press Release - 2002

Sabinsa Corporation's R & D staff have developed and validated an HPLC assay procedure which...

15 July 2002
Sabinsa Corporation Announces The Development of A New Drug to Fight African Sleeping Sickness

Sabinsa Corporation Announces The Development of A New...

Press Release - 2002

Sabinsa Corporation announces the development of a new drug to fight African sleeping sickness. A...

28 May 2002

SPress Relases 2001

Sabinsa Corporation/Sami Labs Receives Two Export Awards From Indian Spices Board

Sabinsa Corporation/Sami Labs Receives Two Export Awards From...

Press Release - 2001

Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that...

07 September 2001
Science Behind ForsLean® Garners Best New Dietary Supplement Product Of The Year Award For Sabinsa

Science Behind ForsLean® Garners Best New Dietary Supplement...

Press Release - 2001

Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that...

17 July 2001
US and Japanese Clinical Trials of Sabinsa's ForsLean® for Weight Management Underway

US and Japanese Clinical Trials of Sabinsa's ForsLean®...

Press Release - 2001

Two new studies have been undertaken to further explore the safety and efficacy of ForsLean...

11 June 2001
Sabinsa Corporation Provides Patent Explanation on ForsLean® Lean Body Mass Supplement

Sabinsa Corporation Provides Patent Explanation on ForsLean® Lean...

Press Release - 2001

In an effort to assist their customers, and potential customers, to understand the scope of...

30 March 2001
Sabinsa Corporation Announces General Availability of ForsLean® Lean Body Mass Supplement

Sabinsa Corporation Announces General Availability of ForsLean® Lean...

Press Release - 2001

Sabinsa Corporation announces that its popular dietary supplement ingredient ForsLean®, a standardized extract from Coleus...

05 March 2001

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.